Active · per the CBE, 17 September 2026

INFI-MED

BE0672499713

Rechtspersoon Private limited company 1 establishment

Rue Quartier du Pachy Hue(FAR) 58, 6240 Farciennes

Active for

9 year, 6 months

Financials

Financial year 2025

INFI-MED from Farciennes, company number BE0672499713, closed financial year 2025 with a result of € 9,978 after tax. For that financial year INFI-MED recorded a gross margin of € 6,521 and equity of € 84,769. Compared with financial year 2024, the result moved from € 7,342 to € 9,978. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.

What it is worth Growing

€ 84,769

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 9,978

▲ 36% vs 2024

Profit after tax over the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 84,768.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 116

▼ 91% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,027

▲ 9% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Revenue € 95,663 € 111,944 - -
Gross margin € 18,200 € 13,839 € 12,967 € 6,521 ▼ 50%
Profit after taxes € 13,629 € 5,774 € 7,342 € 9,978 ▲ 36%
Equity € 61,674 € 67,448 € 74,790 € 84,769 ▲ 13%
Total debts € 308 € 5,768 € 6,828 € 6,160 ▼ 10%
Retained profit € 61,673 € 67,447 € 74,789 € 84,768 ▲ 13%
Balance sheet total € 61,982 € 73,216 € 81,619 € 90,928 ▲ 11%

Key figures of INFI-MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to INFI-MED?

What happened at INFI-MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 9,978 (▲ 36% vs 2024). filed late Source: NBB ↗
  • New establishment in Farciennes. KBO
  • Start of the company according to the CBE. KBO

In short

From € 13,629 profit in 2022 to € 9,978 profit in 2025.

Paid € 29,697 in corporate taxes since 2022.

Best year ever: 2022, with € 13,629 profit.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Quartier du Pachy Hue(FAR) 58

6240 Farciennes

2.262.659.612

Rue Francisco Ferrer(FAR) 62

6240 Farciennes

Active since 8 March 2017

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0672.499.713
VAT number
BE 0672.499.713
Registered office
Rue Quartier du Pachy Hue(FAR) 58, 6240 Farciennes
Names & denominations
INFI-MED
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
8 March 2017
Peppol
Active · Active since 13 Jan 2026

Frequently asked questions

What is the address of INFI-MED?
The registered office of INFI-MED is located at Rue Quartier du Pachy Hue(FAR) 58, 6240 Farciennes.
Is INFI-MED still active?
Yes. According to the CBE (17 September 2026) INFI-MED is active, legal situation “Normale toestand”, started on 8 March 2017.
Is INFI-MED registered on Peppol?
Yes, INFI-MED is registered on the Peppol network with ID 0208:0672499713.
What is the enterprise number of INFI-MED?
The enterprise number of INFI-MED is BE0672499713.
When was INFI-MED founded?
INFI-MED was founded on 8 March 2017.
Is INFI-MED a reliable company?
Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 March 2017; 5 annual accounts filed, latest fiscal year 2025.